No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds MANKIND.NS.
No tracked institution reports a position in MANKIND.NS as of their last filing.
No one on the platform has traded MANKIND.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 10.2% | 15.4% | — | — | — | |
| Rev. Growth % | 17.0% | 18.1% | ||||
| Profit Margin % | 13.4% | 16.3% | ||||
| Free Cash Flow Margin % | 13.2% | 7.8% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $160.6B | +12.5% | $57.15 | $51.42–$64.64 | — | 17 |
| 2028 | $179.1B | +11.6% | $70.43 | $63.07–$79.11 | — | 17 |
| 2029 | $199.1B | +11.1% | $83.77 | $74.46–$97.82 | — | 9 |
| 2030 | $230.0B | +15.5% | $105.56 | $102.92–$110.09 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MANKIND.NSMankind Pharma Limited | $2276.50 | -0.15% | $940.2B | — |
| ALKEM.BOAlkem Laboratories Limited | $5154.75 | +1.28% | $615.4B | — |
| ALKEM.NSAlkem Laboratories Limited | $5213.00 | +2.47% | $623.3B | — |
| DRREDDY.BODr. Reddy's Laboratories Limited | $1159.20 | -0.16% | $974.0B | — |
| DRREDDY.NSDr. Reddy's Laboratories Limited |
| $1157.30 |
| -0.70% |
| $964.0B |
| — |
| LUPIN.BOLupin Limited | $2077.60 | -0.88% | $947.4B | — |
| LUPIN.NSLupin Limited | $2080.30 | -0.70% | $951.2B | — |
Source: Financial Modeling Prep · peers by sector/industry